Abstract
Background Telehealth holds the potential to expand healthcare access for people who use drugs (PWUD). However, approaches to increase PWUDs’ access to digital healthcare are not well-understood. We studied digital healthcare accessibility among PWUD.
Methods We employed respondent-driven sampling to recruit 162 PWUD in Athens, Greece to collect data via a structured questionnaire. Participants were aged at least 18 years and had an injection drug use (IDU) history. We assessed current internet and computer access, and experience with telemedicine. We utilized logistic regression to evaluate sociodemographic associations.
Results Participants’ mean (standard deviation) age was 45.9 (8.8) years, 84.0% were male, 90.1% Greek, 77.8% reported IDU within the past year, 85.2% were not linked to opioid treatment, and 50.0% were currently experiencing homelessness. Only 1.9% had experience and 46.3% had familiarity with telemedicine. Internet and computer access were reported by 66.0% and 31.5% of participants, respectively. Compared to participants with secure housing, those currently experiencing homelessness reported decreased internet (50.6% vs 81.5%, p<0.001) and computer access (11.1% vs 51.9%, p<0.001). Multivariable analyses revealed that older age (per 1-year increase: odds ratio [OR]=0.94, 95% confidence interval [CI] [0.89, 0.99], p=0.03), IDU within the past year (0.29 [0.10, 0.88], p=0.03), and homelessness (0.29, [0.13, 0.65], p=0.003) were associated with lower odds of internet access. Homelessness was associated with lower odds of computer access (0.17, [0.07, 0.41], p<0.001).
Conclusions Internet and infrastructure challenges, homelessness, and digital literacy gaps should be considered to bridge the digital divide and ensure equitable digital healthcare distribution for PWUD.
Clintrials.gov registration number: NCT05794984
Competing Interest Statement
A.H.T. received grants from Merck, Gilead, and Abbott Laboratories and has served as an advisor at Gilead, Novo Nordisk, and AbbVie. VS has received grants from Gilead and AbbVie paid to affiliated institutions, and she has served as a lecturer for Gilead and AbbVie. The remaining authors declare that they have no competing interests.
Funding Statement
Supported by a grant from the Troup Fund of the Kaleida Health Foundation grant awarded to AHT. Clintrials.gov registration number: NCT05794984. Trial registry name: Telemedicine and Social Media for People Who Inject Drugs (PWID) in Greece. URL: https://classic.clinicaltrials.gov/ct2/show/NCT05794984
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Boards of the Hellenic Scientific Society for the Study of AIDS, Sexually Transmitted and Emerging Diseases and the University at Buffalo gave ethical approval for this work. Clintrials.gov registration number: NCT05794984
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The study data are available from the corresponding author upon reasonable request.
